Dvofazna scintigrafija jednjaka u ležećem/stojećem položaju i balon dilatacija kod ahalazije: 20 godina iskustva

  • Zoran Janković Military Medical Academy, Institute for Nuclear Medicine, Belgrade, Serbia
  • Dragan Pucar Military Medical Academy, Institute for Nuclear Medicine, Belgrade, Serbia
  • Radoje Doder University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Nenad Perišić University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Ključne reči: dilatacija balonom, jednjak, jednjak, ahalazija, prognoza, scintigrafija, lečenje, ishod

Sažetak


Uvod/Cilj. Najčešća terapijska metoda za ahalaziju je balon dilatacija (BD). Scintigrafija jednjaka je potencijalno najpogodnija metoda za procenu ahalazije kvantifikovanjem ezofagealnog tranzita. Cilj rada je bio da se prikažu rezultati primene scintigrafije jednjaka (SJ) kod bolesnika sa ahalazijom lečenih BD u periodu od 1997. do 2016. godine i pronalaženje parametara pogodnih za predviđanje rezultata lečenja. Metode. Dvofazna SJ izvođena je u anteriornoj projekciji. Prva faza je rađena u ležećem položaju gutanjem 10 mL vode sa 18,5 MBq 99mTc. Druga faza je izvođena u stojećem položaju nakon gutanja 100 mL vode. Posle scintigrafije, izračunavan je indeks retencije (RI) korišćenjem registrovanih impulsa jednjaka i želuca. Kod 52 bolesnika – 34 muškaraca i 18 žena, životne dobi između 22 i 75 godina života, medijana 44 godine, urađena je SJ pre i posle BD. Kod 31 bolesnika urađene su samo po dve scintigrafije. Kod ostalih 21 bolesnika nastavljeni su praćenje i kontrolne scintigrafije, uključujući i bolesnike s neuspehom i ponovljenim BD. Kod 8 bolesnika, koji su dalje praćeni, ponovljena je BD. Modifikovana BD rađena je primenom Rigiflex balon dilatatora. Rezultati. Tipičan scintigrafski nalaz u ležećem položaju bio je pasivno ispunjavan

 

je jednjaka bez uočljivog motiliteta i kod većine bolesnika, njih 43 (83%), bila je odsutna eliminacija radionuklida u želudac. Procenjujući vrednosti RI pre prve BD i duže vreme posle nje, pokazano je da određene vrednosti RI ukazuju na remisiju ili relaps bolesti. Razlika vrednosti RI posle BD veća od 50% pokazala se kao pouzdan prediktor dugotrajne remisije. Starost i pol bolesnika nisu uticali na rezultat dilatacije, ali su bolesnici mlađi od 40 godina imali veći rizik od ranog neuspeha (6 bolesnika u toku prve godine posle BD). Nalaz SJ ukazao je na to da je prva BD bila inicijalno uspešna kod 50 bolesnika, a posle perioda praćenja kod 41 (79%) bolesnika. Zaključak. Dvofazna scintigrafija jednjaka u ležećem/stojećem položaju je najpogodnija metoda za dijagnostikovanje i praćenje ahalazije. Za procenu i predviđanje terapeutskog odgovora RI je važan pokazatelj. Razlika RI veća od 50% posle BD je pouzdani prediktor duže remisije. Starost i pol bolesnika ne utiču na rezultat dilatacije jednjaka, ali bolesnici mlađi od 40 godina imaju veći rizik od ranog neuspeha lečenja.

Reference

Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manom-etry. Gastroenterology 2013; 145(5): 954–65.

Furuzawa-Carballeda J, Torres-Landa S, Valdovinos MÁ, Coss-Adame E, Martín Del Campo LA, Torres-Villalobos G. New in-sights into the pathophysiology of achalasia and implications for future treatment. World J Gastroenterol 2016; 22(35): 7892‒907.

Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for acha-lasia: late results of a prospective follow up investigation. Gut 2004; 53(5): 629–33.

Doder R, Perišić N, Tomašević R, Mirković D, Janković Z, Djordjević Z. Long term outcome of a modified balloon dilata-tion in the treatment of patients with achalasia. Vojnosanit Pregl 2013; 70(10): 915–22.

Jeon HH, Youn YH, Rhee K, Kim JH, Park H, Conklin JL. For

patients with primary achalasia the clinical success of pneu-matic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy. Dig Dis Sci 2014; 59(2): 375–82.

Cheng P, Shi H, Zhang Y, Zhou H, Dong J, Cai Y, et al. Clinical effect of endoscopic pneumatic dilation for achalasia. Medi-cine 2015; 94(28): e1193.

Moonen A, Annese V, Belmans A, Bredenord AJ, Bruley des Varannes S, Costantini M, et al. Long-term results of the euro-pean achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myo-tomy. Gut 2016; 65(5): 732–9.

Gupta SJ, Gaikwad NR, Samarth AR, Gattewar SR. Pneumatic balloon dilatation for achalasia cardia: outcome, complica-tions, success, and long-term follow-up. Euroasian J Hepato-gastroenterol 2017; 7(2): 138–41.

Robertson CS, Hardy JG, Atkinson M. Quantitative assessment of the response to therapy in achalasia of the cardia. Gut 1989; 30(6): 768–73.

Parker DR, Swift GL, Adams H, Smith PM, Richards AR. Radi-onuclide esophageal transit studies in achalasia before and af-ter balloon dilatation. Dis Esophagus 1996; 9(1): 42‒5.

Chawda SJ, Watura R, Adams H, Smith PM. A comparison of barium swallow and erect esophageal transit scintigraphy fol-lowing balloon dilatation for achalasia. Dis Esophagus 1998; 11(3): 181–7; discussion 187‒8.

Ehsani Ardakani MJ. Esophageal Transit Scintigraphy, Ma-nometry, and Barium Swallow in Assessment of Response to Balloon Dilatation in Achalasia, Iran J Radiol 2006; 4(1): e79230.

Chung JJ, Park HJ, Yu JS, Hong YJ, Kim JH, Kim MJ, Lee SI. A comparison of esophagography and esophageal transit scintig-raphy in the evaluation of usefulness of endoscopic pneumatic dilatation in achalasia. Acta Radiol 2008; 49(5): 498–505.

Stefanidis D, Richardson W, Farrell TM, Kohn GP, Augenstein V, Fanelli RD. Society of American Gastrointestinal and Endo-scopic Surgeons. SAGES guidelines for the surgical treatment of esophageal achalasia. Surg Endosc 2012; 26(2): 296–311.

Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: di-agnosis and management of achalasia. Am J Gastroenterol. 2013; 108(8):1238-49; quiz 1250.

Farhoomand K, Connor JT, Richter JE, Achkar E, Vaezi MF. Pre-dictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol 2004; 2(5): 389–94.

Mehta R, John A, Sadasivan S, Mustafa CP, Nandkumar R, Raj V, et al. Factors determining successful outcome following pneumatic balloon dilatation in achalasia cardia. Indian J Gas-troenterol 2005; 24(6): 243–5.

Dagli U, Kuran S, Savas N, Ozin Y, Alkim C, Atalay F, et al. Factors predicting outcome of balloon dilatation in achalasia. Dig Dis Sci 2009; 54(6): 1237–42.

Tanaka Y, Iwakiri K, Kawami N, Sano H, Umezava M, Kotoyori M, et al. Predictors of a better outcome of pneumatic dilata-tion in patients with primary achalasia. J Gastroenterol 2010; 45(2): 153–8.

Alderliesten J, Conchillo JM, Leeuwenburgh I, Steyerberg EW, Kui-pers EJ. Predictors for outcome of failure of balloon dilatation in patients with achalasia. Gut 2011; 60(1): 10–6.

Yamashita H, Ashida K, Fukuchi T, Nagatani Y, Koga H, Senda K, et al. Predictive factors associated with the success of pneu-matic dilatation in Japanese patients with primary achalasia: a study using high-resolution manometry. Digestion 2013; 87(1): 23–8.

Neyaz Z, Gupta M, Ghoshal UC. How to perform and interpret timed barium esophagogram. J Neurogastroenterol Motil 2013; 19(2): 251–6.

Park YM, Jeon HH, Park JJ, Kim JH, Youn YH, Park H. Corre-lation between timed barium esophagogram and esophageal transit scintigraphy results in achalasia. Dig Dis Sci 2015; 60(8): 2390–7.

Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewitz W, Post J, Kahri-las P. Achalasia: A new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135(5): 1526–33.

Roman S, Gyawali CP, Xiao Y, Pandolfino JE, Kahrilas PJ. The Chicago classification of motility disorders: an update. Gastro-intest Endosc Clin N Am 2014; 24(4): 545–61.

Rohof WOA, Bredenoord AJ. Chicago classification of esophage-al motility disorders: lessons learned. Curr Gastroenterol Rep 2017; 19(8): 37.

Müller M, Eckardt AJ, Wehrmann T. Endoscopic approach to achalasia. World J Gastrointest Endosc 2013; 5(8): 379–90.

Uppal DS, Wang AJ. Update on the endoscopic treatments for achalasia. World J Gastroenterol 2016; 22(39): 8670–83.

Youn YH, Minami H, Chiu PW, Park H. Peroral endoscopic myotomy for treating achalasia and esophageal motility disor-ders. Neurogastroenterol Motil 2016; 22(1): 14–24.

Tuason J, Inoue H. Current status of achalasia management: a review on diagnosis and treatment. J Gastroenterol 2017; 52(4): 401–6.

Arora Z, Thota PN, Sanaka MR. Achalasia: current therapeutic options. Ther Adv Chronic Dis 2017; 8(6–7): 101–8.

Baniya R, Upadhaya S, Khan J, Subedi SK, Shaik Mohammed T, Ganatra BK, et al. Laparoscopic esophageal myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta-analysis of randomized controlled trials. Clin Exp Gas-troenterol 2017; 10: 241–8.

Objavljeno
2021/05/10
Rubrika
Originalni članak